ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Obituaries: Karen Johnson of NCI; Merrill Egorin of UPCI

September 17, 2010

In Brief: Panel to Meet June 9 In Boston; Iverson Takes Position At U. Colo.’Namovicz Leaving NHLBI

May 23, 1986

DCT Advisors Approve Grants Program For Trials Of BRMs

March 10, 1995

NCI Budget: How Did NCI Spend Last Year’s Increase? Klausner Lists Activities

November 19, 1999

Techniclone Wins Patent For Tumor Necrosis Therapy.

February 25, 2000

TV Networks Donate A Prime-Time Hour To Raise Funds For Cancer Research; AACR To Administer Funds, Select Research “Dream Teams.”

May 30, 2008